TransMedics Gr Q3 EPS $0.12 Misses $0.30 Estimate, Sales $108.76M Miss $115.00M Estimate
Portfolio Pulse from Benzinga Newsdesk
TransMedics Group reported Q3 earnings per share of $0.12, missing the $0.30 estimate, and sales of $108.76M, missing the $115M estimate. Despite missing estimates, EPS increased by 115.38% and sales by 63.72% compared to the previous year.
October 28, 2024 | 8:09 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TransMedics Group's Q3 earnings and sales missed analyst estimates, with EPS at $0.12 vs. $0.30 expected and sales at $108.76M vs. $115M expected. However, both EPS and sales showed significant year-over-year growth.
The earnings and sales figures both missed analyst expectations, which is typically negative for stock prices in the short term. However, the significant year-over-year growth in both EPS and sales may mitigate some negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100